COP CompuGroup Medical SE & Co. KGaA

DGAP-News: CompuGroup Medical confirms mid-term ambition at the Capital Markets Day

DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Miscellaneous
CompuGroup Medical confirms mid-term ambition at the Capital Markets Day

01.09.2022 / 09:48 CET/CEST
The issuer is solely responsible for the content of this announcement.


  • CGM well on track for strong revenue growth in 2022
  • Mid-term organic revenue growth of more than 5 % CAGR reconfirmed
  • Adjusted EBITDA Margin improvement post investment phase towards 27 % by 2025
  • Every segment delivers on revenue growth and margin expansion
  • Recently raised guidance for 2022 confirmed

Koblenz. CompuGroup Medical SE & Co. KGaA (CGM), one of the world’s leading e-health providers, today holds its Capital Markets Day 2022 in Koblenz. The Managing Directors and the CGM US CEO give deep insights into the growth opportunities of every segment and how the company’s product offering supports the ongoing digitization in healthcare. 

The company communicated mid-term targets at the prior year’s Capital Markets Day in September 2021 for the first time. During the past twelve months, CGM delivered on those targets, and management confirms the ambition to organically grow at an average annual compound growth rate of 5 percent and more from 2021 to 2025 and to increase the adjusted EBITDA margin to approximately 25 % in 2023 and to approximately 27 % in 2025. The share of recurring revenue, which underlines the high resilience of CGM’s business, is expected to increase to more than 70 % in 2025.

“With the comprehensive product portfolio, CGM is ideally positioned to support all healthcare practitioners with the changing requirements in the healthcare sector. The digital patient journey is becoming reality and we provide all building blocks for the needs of our customers”, says the Spokesman for the Managing Directors & CFO Michael Rauch “Every segment is committed to deliver increased returns from the investments initiated in 2021 with Q4-2022 being the first proof point.”

Further information on the Capital Markets Day 2022 are available for download on the company website under .


About CompuGroup Medical SE & Co. KGaA 
CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 1.025 billion in 2021, its software products are designed to support all medical and organizational activities in doctors’ offices, pharmacies, laboratories, hospitals and social welfare institutions. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical’s services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other healthcare professionals in inpatient and outpatient facilities. With locations in 19 countries and products in 56 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals. More than 8,500 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Contact for Media Representatives:
Alexander Weimer
Head of Corporate Communications
T 00
M

Contact for Analysts and Investors:
Claudia Thomé
Corporate Vice President Investor Relations
T
M


01.09.2022 CET/CEST Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)160 3630362
Fax: +49 (0)261 8000 3200
E-mail:
Internet:
ISIN: DE000A288904
WKN: A28890
Indices: SDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1432759

 
End of News DGAP News Service

1432759  01.09.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1432759&application_name=news&site_id=research_pool
EN
01/09/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CompuGroup Medical SE & Co. KGaA

 PRESS RELEASE

EQS-News: CGM proposes dividend of EUR 1.00 to be passed at virtual AG...

EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): AGM/EGM/Dividend CGM proposes dividend of EUR 1.00 to be passed at virtual AGM in May 10.04.2024 / 15:26 CET/CEST The issuer is solely responsible for the content of this announcement. CGM proposes dividend of EUR 1.00 to be passed at virtual AGM in May Virtual Annual General Meeting on May 22, 2024 Agenda for the AGM published Dividend doubled to EUR 1.00   Koblenz - CompuGroup Medical SE & Co. KGaA (CGM) will hold its Annual General Meeting on May 22 again virtually this year. The virtual AGM format will en...

 PRESS RELEASE

EQS-News: CGM schlägt Dividende von EUR 1,00 zur Verabschiedung auf de...

EQS-News: CompuGroup Medical SE & Co. KGaA / Schlagwort(e): Hauptversammlung/Dividende CGM schlägt Dividende von EUR 1,00 zur Verabschiedung auf der virtuellen Jahreshauptversammlung im Mai vor 10.04.2024 / 15:26 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. CGM schlägt Dividende von EUR 1,00 zur Verabschiedung auf der virtuellen Jahreshauptversammlung im Mai vor   Virtuelle Jahreshauptversammlung am 22. Mai 2024 Tagesordnung für die Hauptversammlung veröffentlicht Verdoppelung der Dividende auf EUR 1,00   Koblenz – CompuGrou...

 PRESS RELEASE

EQS-News: CompuGroup Medical USA kündigt Staffelstabübergabe in der CE...

EQS-News: CompuGroup Medical SE & Co. KGaA / Schlagwort(e): Personalie CompuGroup Medical USA kündigt Staffelstabübergabe in der CEO-Position des US-Geschäfts an 25.03.2024 / 12:32 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. CompuGroup Medical USA kündigt Staffelstabübergabe in der CEO-Position des US-Geschäfts an   Austin, Texas – CompuGroup Medical (CGM) ernennt Benedikt Brueckle mit Wirkung zum 1. Januar 2025 zum neuen Chief Executive Officer für die USA. Damit kommt es zur Staffelstabübergabe in der Führung des US-Geschäft...

 PRESS RELEASE

EQS-News: CompuGroup Medical US announces CEO transition

EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Personnel CompuGroup Medical US announces CEO transition 25.03.2024 / 12:32 CET/CEST The issuer is solely responsible for the content of this announcement. CompuGroup Medical US announces CEO transition   Austin, TX – Underlining the commitment to its second largest market worldwide by revenue, CompuGroup Medical announces the appointment of Benedikt Brueckle as its new Chief Executive Officer for the US, effective January 1, 2025. Benedikt Brueckle is a respected and experienced leader in the healthcare IT indus...

 PRESS RELEASE

EQS-News: CGM plans to double its dividend

EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Dividend CGM plans to double its dividend 20.02.2024 / 20:37 CET/CEST The issuer is solely responsible for the content of this announcement. CGM plans to double its dividend Koblenz. The general partner of CompuGroup Medical SE & Co. KGaA (CGM) intends to sustainably increase the dividend to a higher level, and will therefore propose a dividend of EUR 1.00 per share to the Annual General Meeting for the financial year 2023. Based on the 52.2 million shares currently entitled to a dividend payment, the planned tota...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch